Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Abstract
Increased generation of reactive oxygen species (ROS) and an altered redox status have long been observed in cancer cells, and recent studies suggest that this biochemical property of cancer cells can be exploited for therapeutic benefits. Cancer cells in advanced stage tumours frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially eliminate these cells by pharmacological ROS insults. However, the upregulation of antioxidant capacity in adaptation to intrinsic oxidative stress in cancer cells can confer drug resistance. Abrogation of such drug-resistant mechanisms by redox modulation could have significant therapeutic implications. We argue that modulating the unique redox regulatory mechanisms of cancer cells might be an effective strategy to eliminate these cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, available data suggest that MGF-driven restoration of redox homeostasis represents a central mechanistic axis of its antitumor activity, rather than merely a downstream branch of apoptosis (84,85).”
From Mangiferin in human disease: Multifaceted mechanisms and applications (Review) (2026) · cites this paper as [84]
In the citing paper
“Activation of oncogenes, aberrant metabolism, mitochondrial dysfunction, and loss of the tumor suppressor p53 can all promote increased ROS accumulation in cancer cells 69.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [69]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379 · cited 1×
“It has been observed that a small subpopulation of primary cancer cells expressing stem-cell markers was resistant to certain chemotherapeutic agents and radiatio”
BackgroundSchafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587 · cited 1×
“A moderate increase in ROS can promote cell proliferation and differentiatio”
BackgroundFive-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M. W. N., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,488 · cited 1×
“By exploiting the genetic differences between normal cells and cancer cells, several molecular-targeted drugs, such as imatinib (Gleevec; Novartis) and trastuzumab (Herceptin; Genentech/Roche), show promising therapeutic activity and few toxic side effect”
BackgroundCancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429 · cited 1×
“Redox status in cancer stem cells Recurrence of cancer after chemotherapy or radiotherapy is initiated by a subpopulation of residual malignant cells that are highly resistant to treatment and which are believed to be cancer-initiating cells or cancer stem cell”
Background(2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,178
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 3,007
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555 · cited 1×
“Recent studies showed that normal haemopoietic stem cells and normal mammary epithelial stem cells maintained ROS at lower levels than their mature progeny to prevent cellular differentiation and maintain long-term self-renewa”
BackgroundBjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007) · JAMA · doi:10.1001/jama.297.8.842 · Cited by 2,275
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272 · cited 1×
“This is consistent with the high incidence of p53 mutation or loss of p53 function in over 50% of human cancer”
Background
Research works printed but not linked: 1
- Kim, G. J., Chandrasekaran, K. & Morgan, W. F. Mitochondrial dysfunction, persistently elevated levels of reactive oxygen species and radiation-induced genomic instability: a review. Mutagenesis 21, 361–367 (2006). · DOI · Paper page
Cited by
Items 801–900 of 1,014
Zhou, J., Zhao, Y., Bao, J., Huo, D., Fa, H., Shen, X., & Hou, C. (2017) · Electrochimica Acta · doi:10.1016/j.electacta.2017.08.044 · Cited by 98
Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics
Frey, N., Venturelli, S., Zender, L., & Bitzer, M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.146 · Cited by 97
Exploiting Mitochondrial Vulnerabilities to Trigger Apoptosis Selectively in Cancer Cells
Nguyen, C. C., & Pandey, S. (2019) · Cancers · doi:10.3390/cancers11070916 · Cited by 103
The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?
Glorieux, C., Enriquez-Lara, C., González, C. D., Aguirre-Martínez, G. V., & Calderón, P. B. (2024) · Antioxidants · doi:10.3390/antiox13010070 · Cited by 104
“Nevertheless, tumor cells can develop adaptive mechanisms in response to such heightened ROS levels by increasing their antioxidant capacity, thereby reducing ROS to non-toxic levels while preserving pro-tumorigenic signaling, promoting genetic instability, and resisting apoptosis [16].”
BackgroundGundala, S. R., Yang, C., Mukkavilli, R., Paranjpe, R., Brahmbhatt, M., Pannu, V., Cheng, A. S., Reid, M. D., & Aneja, R. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.07.012 · Cited by 109
“Literature reports suggest that cancer cells possess higher concentrations of reactive oxygen species (ROS) compared to normal cells (Szatrowski and Nathan, 1991; Schumacker, 2006; Trachootham et al., 2009b).”
BackgroundInfluentialOrganotin(IV)‐Loaded Mesoporous Silica as a Biocompatible Strategy in Cancer Treatment
Bulatović, M., Maksimović‐Ivanić, D., Bensing, C., Gómez‐Ruiz, S., Steinborn, D., Schmidt, H., Mojić, M., Korać, A., Golić, I., Pérez‐Quintanilla, D., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201400763 · Cited by 99
Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer
Gaascht, F., Dicato, M. A., & Diederich, M. F. (2015) · Genes & Nutrition · doi:10.1007/s12263-015-0501-3 · Cited by 115
Gopal, S. S., Prasad, K. Y., Arpitha, H. S., Rudresh, D. U., Kumar, K. N., Mondal, P., & Ponesakki, G. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3071-4 · Cited by 109
Mechanisms of Plasma Medicine: Coupling Plasma Physics, Biochemistry, and Biology
Graves, D. B. (2017) · IEEE Transactions on Radiation and Plasma Medical Sciences · doi:10.1109/trpms.2017.2710880 · Cited by 103
“eral years, there have been multiple studies that point out the connection between RONS and cancer therapeutics [48].”
BackgroundGenotoxicity of amorphous silica nanoparticles: Status and prospects
Yazdimamaghani, M., Moos, P. J., Dobrovolskaia, M. A., & Ghandehari, H. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.11.013 · Cited by 101
Koklesová, L., Líšková, A., Samec, M., Qaradakhi, T., Zulli, A., Šmejkal, K., Kajo, K., Jakubíková, J., Behzadi, P., Péč, M. J., et al. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00210-5 · Cited by 96
Rawat, L., Hegde, H. V., Hoti, S. L., & Nayak, V. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110243 · Cited by 104
Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment
Qin, J., Gong, N., Liao, Z., Zhang, S., Timashev, P. S., Huo, S., & Liang, X. (2021) · Nanoscale · doi:10.1039/d1nr01068a · Cited by 100
Synthetic biology-instructed transdermal microneedle patch for traceable photodynamic therapy
He, G., Li, Y., Younis, M. R., Fu, L., He, T., Shan, L., Lin, J., & Huang, P. (2022) · Nature Communications · doi:10.1038/s41467-022-33837-1 · Cited by 97
“Such physiological PpIX metabolic kinetics limits 5-ALA-PDT of malignant tumors in a hypoxic microenvironment, as conventional 5-ALA-PDT for malignant tumors usually induces more serious recurrence and metastasis 4,5,53 .”
Self-citationROS homeostasis in cell fate, pathophysiology, and therapeutic interventions
Chen, Y.-S., Tian, H., Rong, D., Wang, L., Chen, S., Zeng, J., Xu, H., Mei, J., Wang, L.-Y., Liou, Y., et al. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00338-8 · Cited by 112
“ROS play a concentration-dependent dual role in cancer [383].”
Activation of ERK signaling and induction of colon cancer cell death by piperlongumine
Randhawa, H., Kibble, K., Zeng, H., Moyer, M. P., & Reindl, K. M. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.04.006 · Cited by 97
“As a result, cancer cells, but not healthy cells, are unable to recover from additional oxidative stress and die (Schumacker, 2006; Trachootham et al., 2009).”
Li, X., Feng, J., & Sun, R. (2010) · Journal of Virology · doi:10.1128/jvi.01742-10 · Cited by 102
“ROS are known to play important roles in cell death (23, 63).”
BackgroundThe Intercellular Metabolic Interplay between Tumor and Immune Cells
Wang, T., Liu, G., & Wang, R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00358 · Cited by 97
“Heightened GSH level is observed in numerous types of cancers, and the enriched GSH improves tumor cell survival by protecting them against oxidative stress (73, 74).”
BackgroundLeveraging H2O2Levels for Biomedical Applications
Wang, J., Zhang, Y., Ogunnaike, E. A., Ligler, F. S., & Gu, Z. (2017) · Advanced Biosystems · doi:10.1002/adbi.201700084 · Cited by 99
Jin, G., Feng, G., Qin, W., Tang, B. Z., Liu, B., & Li, K. (2016) · Chemical Communications · doi:10.1039/c5cc07818k · Cited by 95
Shaaban, S., Negm, A., Ashmawy, A. M., Ahmed, D. M., & Wessjohann, L. A. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.06.005 · Cited by 95
Zhang, X., Cheng, L., Lu, Y., Tang, J., Lv, Q., Chen, X., Chen, Y., & Liu, J. (2021) · Nano-Micro Letters · doi:10.1007/s40820-021-00761-w · Cited by 98
Mitochondrial Transfer as a Novel Therapeutic Approach in Disease Diagnosis and Treatment
Clemente‐Suárez, V. J., Martín-Rodríguez, A., Sepulveda, R. A. Y., & Tornero-Aguilera, J. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108848 · Cited by 108
Stimuli‐Responsive PROTACs for Controlled Protein Degradation
An, K., Deng, X., Chi, H., Zhang, Y., Li, Y., Cheng, M., Ni, Z., Yang, Z., Wang, C., Chen, J., et al. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202306824 · Cited by 107
Tarin, M., Babaie, M., Eshghi, H., Matin, M. M., & Saljooghi, A. S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04533-5 · Cited by 102
“Increased metabolism in cancer cells results in elevated levels of superoxide and ROS in mitochondria [35].”
BackgroundReddy, T. S., Kulhari, H., Reddy, V. G., Rao, A., Bansal, V., Kamal, Ä., & Shukla, R. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00842e · Cited by 98
Shin, W. S., Lee, M.-G., Verwilst, P., Lee, J. H., Chi, S.-G., & Kim, J. S. (2016) · Chemical Science · doi:10.1039/c6sc02236g · Cited by 95
Lyu, Q., Zhai, Q., Dyson, J. M., Gong, S. P., Zhao, Y., Ling, Y., Chandrasekaran, R., Dong, D., & Cheng, W. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b02610 · Cited by 94
Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications
Živojević, K., Mladenović, M., Djisalov, M., Mundžić, M., Ruiz‐Hernández, E., Gadjanski, I., & Knežević, N. Ž. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.07.029 · Cited by 99
Near-infrared light-triggered nano-prodrug for cancer gas therapy
Liu, R., Peng, Y., Lu, L., Peng, S., Chen, T., & Zhan, M. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01078-x · Cited by 97
Živanić, M., Espona‐Noguera, A., Lin, A. G., & Canal, C. (2023) · Advanced Science · doi:10.1002/advs.202205803 · Cited by 105
Lian, C., Liu, J., Wei, W., Wu, X., Goto, T., Li, H., Tu, R., & Dai, H. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.04.028 · Cited by 146
“Low concentrations of ROS produced by cellular metabolism are essential for physiological processes [6,7].”
BackgroundSynthesis and antioxidant activities of 2-oxo-quinoline-3-carbaldehyde Schiff-base derivatives
Zhang, Y., Fang, Y., Liang, H., Wang, H., Hu, K., Liu, X., Yi, X., & Peng, Y. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.11.006 · Cited by 94
Acidosis promotes invasiveness of breast cancer cells through ROS-AKT-NF-κB pathway
Gupta, S. C., Singh, R., Pochampally, R. R., Watabe, K., & Mo, Y. (2014) · Oncotarget · doi:10.18632/oncotarget.2514 · Cited by 94
“Therefore, this high level of ROS in cancer cells may help them to achieve the acidosis-induced signaling cascades [43].”
BackgroundExcessive Reactive Oxygen Species and Exotic DNA Lesions as an Exploitable Liability
AbdulSalam, S. F., Thowfeik, F. S., & Merino, E. J. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00703 · Cited by 101
Oxidative Stress, Nrf2, and Epigenetic Modification Contribute to Anticancer Drug Resistance
Kang, K. A., & Hyun, J. W. (2017) · Toxicological Research · doi:10.5487/tr.2017.33.1.001 · Cited by 95
Dai, F., Li, Q., Wang, Y., Ge, C., Feng, C., Xie, S., He, H., Xu, X., & Wang, C. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01846 · Cited by 94
Sharma, P., Reddy, T. S., Kumar, N. P., Senwar, K. R., Bhargava, S. K., & Shankaraiah, N. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.035 · Cited by 94
Implications of red Panax ginseng in oxidative stress associated chronic diseases
Lee, Y.-M., Yoon, H., Park, H., Song, B. C., & Yeum, K. (2016) · Journal of Ginseng Research · doi:10.1016/j.jgr.2016.03.003 · Cited by 96
“ROS are constantly produced from mitochondria via the respiratory chain and the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase system, and can be eliminated by enzymatic and non-enzymatic ROS scavenging factors, such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glut…”
BackgroundMitochondria-Centric Review of Polyphenol Bioactivity in Cancer Models
Stevens, J. F., Revel, J. S., & Maier, C. S. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7404 · Cited by 101
“However, cancer cells exhibit enhanced oxidative stress levels and production of ROS (compared with normal cells) due to their high energy demands (56, 196).”
Inhibition of NPC1L1 disrupts adaptive responses of drug‐tolerant persister cells to chemotherapy
Zhang, Z., Qin, S., Chen, Y., Zhou, L., Yang, M. X., Tang, Y., Zuo, J., Zhang, J., Mizokami, A., Nice, E. C., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202114903 · Cited by 97
Recent Development of Prodrugs of Gemcitabine
Pandit, B., & Royzen, M. (2022) · Genes · doi:10.3390/genes13030466 · Cited by 96
Song, W., Zeng, J., Ji, P., Han, Z., Sun, Y., & Zhang, X. (2023) · Small · doi:10.1002/smll.202301148 · Cited by 93
Kai, K., Arima, Y., Kamiya, T., & Saya, H. (2009) · Breast Cancer · doi:10.1007/s12282-009-0176-y · Cited by 94
Mitochondrial ion channels as oncological targets
Leanza, L., Zoratti, M., Gulbins, E., & Szabó, I. (2014) · Oncogene · doi:10.1038/onc.2013.578 · Cited by 99
Nakayama, M., Sasaki, R., Ogino, C., Tanaka, T., Morita, K., Umetsu, M., Ohara, S., Tan, Z., Nishimura, Y., Akasaka, H., et al. (2016) · Radiation Oncology · doi:10.1186/s13014-016-0666-y · Cited by 92
Determination of Cell Membrane Capacitance and Conductance via Optically Induced Electrokinetics
Liang, W., Zhao, Y., Liu, L., Wang, Y., Li, W. J., & Lee, G. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.08.006 · Cited by 92
“In general, cell intrinsic information, which can be used to guide biomedical and bioengineering applications, such as disease diagnosis and pharmaceutical development, can be obtained through biochemical techniques (6).”
BackgroundRationally Optimized Fluorescent Probe for Imaging Mitochondrial SO2 in HeLa Cells and Zebrafish
Chen, G., Zhou, W., Zhao, C., Liu, Y., Chen, T., Li, Y., & Tang, B. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01505 · Cited by 93
Liang, H., Zhou, Z., Luo, R., Sang, M., Liu, B., Sun, M., Qu, W., Feng, F., & Liu, W. (2018) · Theranostics · doi:10.7150/thno.28344 · Cited by 92
“However, the high GSH concentration in the cytoplasm of tumor cells is important for adjusting intrinsic oxidative stress, thereby hindering ROS generation [35].”
A cobalt-doped iron oxide nanozyme as a highly active peroxidase for renal tumor catalytic therapy
Wang, Y., Li, H., Guo, L., Jiang, Q., & Liu, F. (2019) · RSC Advances · doi:10.1039/c8ra05487h · Cited by 92
Organometallic compounds in drug discovery: Past, present and future
Ong, Y. C., & Gasser, G. (2019) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2019.06.001 · Cited by 98
Wang, Y., Ding, Y., Yao, D., Dong, H., Ji, C., Wu, J., Hu, Y., & Yuan, A. (2021) · Small · doi:10.1002/smll.202006231 · Cited by 101
Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role
Barrera, G., Cucci, M. A., Grattarola, M., Dianzani, C., Muzio, G., & Pizzimenti, S. (2021) · Antioxidants · doi:10.3390/antiox10040510 · Cited by 103
“Chemoresistant cancer cells becom highly adapted to intrinsic or drug-induced oxitive stress by upregulating their antioxidant systems [22,23] (Figure 2).”
BackgroundCell Membrane-Coated Biomimetic Nanoparticles in Cancer Treatment
Zhang, S., Zhang, X., Gao, H., Zhang, X., Sun, L., Huang, Y., Zhang, J., & Ding, B. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040531 · Cited by 107
“Beyond the examples previously discussed, research has explored hybrids of cancer–cancer [91], DC–cancer [92], RBC–PLT [139], mitochondria–cancer [140], bacteria–cancer [141], and embryonic–bacteria [142], among others.”
BackgroundMorinaka, A., Funato, Y., Uesugi, K., & Miki, H. (2011) · Oncogene · doi:10.1038/onc.2011.139 · Cited by 97
“…it has been indicated that cancer cells are very sensitive to artificial ROS elevation because most cancer cells are chronically subjected to oxidative stress and an additional increase in ROS levels brings the level of oxidative stress to a fatal degree (reviewed by Trachootham et al., 2009).”
BackgroundCiamporcero, E. S., Daga, M., Pizzimenti, S., Roetto, A., Dianzani, C., Compagnone, A., Palmieri, A., Ullio, C., Cangemi, L., Пили, Р., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.005 · Cited by 93
“production induced by cytotoxic therapeutic agents, such as cisplatin or doxorubicin, which trigger oxidative stress by binding to cytoplasmic nucleophilic species, including glutathione (GSH), and other cysteinerich proteins, and induce cancer cell senescence and death [3].”
CPX Targeting DJ-1 Triggers ROS-induced Cell Death and Protective Autophagy in Colorectal Cancer
Zhou, J., Zhang, L., Wang, M., Zhou, L., Feng, X., Yu, L., Lan, J., Gao, W. Q., Zhang, C., Bu, Y., et al. (2019) · Theranostics · doi:10.7150/thno.34663 · Cited by 96
“It has been widely considered that therapeutic stimulation of ROS can be a potent strategy to preferentially eliminate cancer cells [55, 56].”
BackgroundAnticancer Drugs Targeting the Mitochondrial Electron Transport Chain
Rohlena, J., Dong, L.-F., Ralph, S. J., & Neuzil, J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3990 · Cited by 91
“…factor 1 (HIF1), and Myc upregulation and corresponding increase in glutamine metabolism (45, 108, 206), downregulation of complex V (CV) function (43), elevated mitochondrial membrane potential (11, 49, 84, 138, 190), and increased propensity to generate reactive oxygen species (ROS) (196).”
Beyond Fmoc: a review of aromatic peptide capping groups
Martin, A. D., & Thordarson, P. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02539a · Cited by 91
Biochemical pathways of copper complexes: progress over the past 5 years
Zehra, S., Tabassum, S., & Arjmand, F. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.01.015 · Cited by 92
Nanozyme as Tumor Energy Homeostasis Disruptor to Augment Cascade Catalytic Therapy
Li, X., Zhang, X., Song, L., Li, Y., Liu, A., Li, L., Nešić, M. D., Li, D., Peng, L., Wang, C., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c09982 · Cited by 94
Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer
Chen, D., Guo, Z., Yao, L., Sun, Y., Dian, Y., Zhao, D., Ke, Y., Zeng, F., Zhang, C., Deng, G., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103686 · Cited by 106
“These adaptations collectively enable tumor cells to evade ROS-mediated cytotoxicity, necessitating combinatorial targeting strategies [7,532].”
InfluentialDarsigny, M., Babeu, J., Seidman, E. G., Gendron, F., Levy, E. H., Carrier, J. C., Perreault, N., & Boudreau, F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1697 · Cited by 91
Chen, W., Zou, P., Zhao, Z., Chen, X., Fan, X., Rajamanickam, V., Cui, R., Wu, F., Zhang, Q., Liang, G., et al. (2016) · Redox Biology · doi:10.1016/j.redox.2016.09.006 · Cited by 93
“As a result, cancer cells are believed to be unable to cope with additional oxidative stress and become sensitive to agents that increase ROS levels [17].”
BackgroundDou, K., Chen, G., Yu, F., Liu, Y., Chen, L., Cao, Z., Chen, T., Li, Y., & You, J. (2017) · Chemical Science · doi:10.1039/c7sc03719h · Cited by 90
Significant effects of counteranions on the anticancer activity of iridium( iii ) complexes
Zhang, H., Guo, L., Tian, Z., Tian, M., Zhang, S., Xu, Z., Gong, P., Zheng, X., Zhao, J. Y., & Liu, Z. (2018) · Chemical Communications · doi:10.1039/c8cc01326h · Cited by 90
Huang, Y., Jiang, Y., Xiao, Z., Shen, Y., Huang, L., Xu, X., Wei, G., Xu, C., & Zhao, C. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.122369 · Cited by 93
Chen, W., Lian, W., Yuan, Y., & Li, M. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1824-6 · Cited by 92
Pan, Q., Zhang, B., Peng, X., Wan, S., Luo, K., Gao, W., Pu, Y., & He, B. (2019) · Chemical Communications · doi:10.1039/c9cc05438c · Cited by 90
Wang, D., Cui, L.-H., Chang, X., & Guan, D. (2019) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2019.111652 · Cited by 99
Cheng, J., Wang, X., Qiu, L., Li, Y., Marraiki, N., Elgorban, A. M., & Li, X. (2019) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2019.111644 · Cited by 90
Privat‐Maldonado, A., Bengtson, C., Razzokov, J., Smits, E., & Bogaerts, A. (2019) · Cancers · doi:10.3390/cancers11121920 · Cited by 91
“This makes cancer cells more vulnerable to high ROS levels, increasing their sensitivity and apoptosis from increased ROS [22].”
BackgroundWang, Y., An, L., Lin, J., Tian, Q., & Yang, S. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.123925 · Cited by 90
Wang, X., Zhao, H., Liu, Z., Wang, Y., Lin, D., Chen, L., Dai, J., Lin, K., & Shen, S. G. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.129284 · Cited by 91
Redox dyshomeostasis strategy for tumor therapy based on nanomaterials chemistry
Wu, Y., Li, Y., Lv, G., & Bu, W. (2022) · Chemical Science · doi:10.1039/d1sc06315d · Cited by 91
The Potent Oxidant Anticancer Activity of Organoiridium Catalysts
Liu, Z., Romero‐Canelón, I., Qamar, B., Hearn, J. M., Habtemariam, A., Barry, N. P. E., Pizarro, A. M., Clarkson, G. J., & Sadler, P. J. (2014) · Angewandte Chemie · doi:10.1002/ange.201311161 · Cited by 90
Ali, T., Li, D., Ponnamperumage, T. N. F., Peterson, A. K., Pandey, J., Fatima, K., Brzezinski, J., Jakusz, J. A. R., Gao, H., Koelsch, G. E., et al. (2024) · Cancers · doi:10.3390/cancers16122171 · Cited by 95
“This intrinsic feature of cancer paves the way for the development of tumor-selective therapeutic strategies [3,6–9].”
BackgroundChemistry and Biology of Deoxynyboquinone, a Potent Inducer of Cancer Cell Death
Bair, J. S., Palchaudhuri, R., & Hergenrother, P. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja100610m · Cited by 107
Wei, L., Zhou, Y., Qiao, C., Ni, T., Li, Z., You, Q., Guo, Q., & Lu, N. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.86 · Cited by 93
“through the regulation of phosphatases and transcription factors.(15) OA is a flavonoid that exhibits multiple pharmacological activities, including antioxidative, anti-inflammatory, anti-viral, and anti-tumor properties.”
BackgroundInfluentialPromiscuous methionyl-tRNA synthetase mediates adaptive mistranslation against oxidative stresses
Lee, J. Y., Kim, D. G., Kim, B., Yang, W. S., Hong, J., Kang, T., Oh, Y. S., Kim, K. R., Han, B. W., Hwang, B., et al. (2014) · Journal of Cell Science · doi:10.1242/jcs.152470 · Cited by 95
“Maintaining redox homeostasis is therefore essential for normal cell growth and survival (Trachootham et al., 2009).”
BackgroundLiu, B., Tan, X., Liang, J., Wu, S., Liu, J., Zhang, Q., & Zhu, R. (2014) · Scientific Reports · doi:10.1038/srep07041 · Cited by 90
Lunov, O., Zablotskii, V., Churpita, O., Chánová, E. M., Syková, E., Dejneka, A., & Kubinová, Š. (2014) · Scientific Reports · doi:10.1038/srep07129 · Cited by 97
Targeting Aldose Reductase for the Treatment of Cancer
Tammali, R., Sk, S., & Ramana, K. V. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911795655958 · Cited by 90
He, C., Jiang, S., Jin, H., Chen, S., Lin, G., Yao, H., Wang, X., Mi, P., Ji, Z., Lin, Y., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.010 · Cited by 90
“proposed that cancer cells are more sensitive to exogenous oxidative stress [35,42], such as that imposed by ROS.”
BackgroundBrazzale, C., Canaparo, R., Racca, L., Foglietta, F., Durando, G., Fantozzi, R., Caliceti, P., Salmaso, S., & Serpe, L. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0293 · Cited by 88
“These results suggest that the cytotoxicity induced by the sonoactiovation of FA-PEG-GNP therefore does not only depend on the degree of FR over-expression, but also on the intrinsic cell sensitivity to the treatment outcomes, namely ROS [45].”
Nrf2 Mutagenic Activation Drives Hepatocarcinogenesis
Ngo, H. K. C., Kim, D.-H., Cha, Y.-N., Na, H.-K., & Surh, Y.-J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3538 · Cited by 87
“Many different types of cancers are known to express elaborated levels of ROS (41).”
BackgroundInfluentialTargeting the Selenoprotein Thioredoxin Reductase 1 for Anticancer Therapy
Arnér, E. S. J. (2017) · Advances in cancer research · doi:10.1016/bs.acr.2017.07.005 · Cited by 98
Guan, Q., Li, Y., Li, W., & Dong, Y. (2018) · Chemistry - An Asian Journal · doi:10.1002/asia.201801221 · Cited by 92
Responsive boron biomaterials and their biomedical applications
Chen, W., Xu, Z. C., Wu, W., & Jiang, X. (2020) · Science China Chemistry · doi:10.1007/s11426-019-9699-3 · Cited by 91
Bai, S., Zhang, Y., Li, D., Shi, X., Lin, G., & Liu, G. (2021) · Nano Today · doi:10.1016/j.nantod.2020.101038 · Cited by 89
Chen, J., Wang, Y., Niu, H., Wang, Y., Wu, A., Shu, C., Zhu, Y., Bian, Y., & Lin, K. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c11032 · Cited by 90
Responsive Hydrogels Based on Triggered Click Reactions for Liver Cancer
Zhu, J., Wu, H., Li, Z., Xu, X., Xing, H., Wang, M.-D., Jia, H., Liang, L., Li, C., Sun, L., et al. (2022) · Advanced Materials · doi:10.1002/adma.202201651 · Cited by 92
The Impact of Tobacco Cigarettes, Vaping Products and Tobacco Heating Products on Oxidative Stress
Emma, R., Caruso, M., Campagna, D., Pulvirenti, R., & Volti, G. L. (2022) · Antioxidants · doi:10.3390/antiox11091829 · Cited by 102
Zhou, J., Fang, C., Rong, C., Luo, T., Liu, J., & Zhang, K. (2023) · Smart Materials in Medicine · doi:10.1016/j.smaim.2023.01.004 · Cited by 85
Low-Temperature Plasma Techniques in Biomedical Applications and Therapeutics: An Overview
Karthik, C., Chand, S., & Thomas, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010524 · Cited by 94
In vivo demonstration of enhanced radiotherapy using rare earth doped titania nanoparticles
Townley, H. E., Kim, J., & Dobson, P. J. (2012) · Nanoscale · doi:10.1039/c2nr30769c · Cited by 96
Jeschke, J., O’Hagan, H. M., Zhang, W., Vatapalli, R. J., Calmon, M. F., Danilova, L., Nelkenbrecher, C., Neste, L. V., Bijsmans, I. T. G. W., van Engeland, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3751 · Cited by 96
“CDO1-induced reduction in ROS detoxification sensitizes breast cancer cells to anthracycline treatment Anthracyclines, such as doxorubicin, are cytotoxic ROSgenerating chemotherapeutic agents (27)widely used in the treatment of breast cancer.”
BackgroundInfluentialChen, G., Chen, Z., Hu, Y., & Huang, P. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4170 · Cited by 89
“…and, thus, highly dependent on GSH to keep redox balance, abrogation of the GSH system by PEITC would have a detrimental impact on cancer cells, whereas such redox modulation can be better tolerated by normal cells due to their low basal ROS output and intact redox regulatory mechanisms (38).”
Self-citationThiol regulation by Mn porphyrins, commonly known as SOD mimics
Batinic-Haberle, I., & Tome, M. E. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101139 · Cited by 88
“One hypothesis for the use of chemotherapeutics that cause oxidative stress to increase cell death in tumor cells is that they exploit the difference in oxidant load between normal and cancer cells [70,71].”
BackgroundLiao, Y.-J., Bai, H.-Y., Li, Z. H., Zou, J., Chen, J.-W., Zheng, F., Zhang, J. X., Mai, S.-J., Zeng, M.-S., Sun, H., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.66 · Cited by 89
“significantly so that any further acute increases can trigger reactivation of the apoptotic program in cancer cells.(18)”
BackgroundMethod
Metadata
- Authors
- Trachootham, D., Alexandre, J., & Huang, P.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Huang, Peng
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-05-29
- Volume
- 8
- Issue
- 7
- Pages
- 579-591
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1972779889
- Cited by
- 5,452
- References
- 163
- Citations by year
- 2026: 322 · 2025: 332 · 2024: 340 · 2023: 372 · 2022: 421 · 2021: 462 · 2020: 444 · 2019: 454 · 2018: 393 · 2017: 404 · 2016: 341 · 2015: 289 · 2014: 282 · 2013: 204 · 2012: 158
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA085563, R01CA109041, CA109041, R01CA085563, R01CA100428, CA100428)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- reactive oxygen species, oxidative stress, redox modulation, cancer cells, drug resistance, antioxidant capacity, anticancer agents, genomic instability
- MeSH terms
- Adaptation, Physiological, Animals, Glutathione, Humans, Neoplasms, Oxidation-Reduction, Neoplastic Stem Cells, Reactive Oxygen Species, Drug Resistance, Neoplasm
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.